SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
Filed by the Registrant [ ]
Filed by a Party other than the Registrant [X]
Check the appropriate box:
[X] Preliminary Proxy Statement [ ] Confidential, For Use of the
Commission Only (as
[ ] Definitive Proxy Statement permitted by Rule 14a-6(e)(2))
[ ] Definitive Additional Materials
[ ] Soliciting Material Pursuant to
Rule 14a-11(c) or Rule 14a-12
Global Motorsport Group, Inc.
------------------------------------------
(Name of Registrant as Specified in Its Charter)
Golden Cycle, LLC
------------------------------------------
(Name of Person(s) Filing Proxy Statement (if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
1) Title of each class of securities to which transaction applies:
N/A
2) Aggregate number of securities to which transaction applies:
N/A
3) Per unit price or other underlying value of
transaction computed pursuant to Exchange Act Rule
0-11 (set forth the amount on which the filing fee is
calculated and state how it was determined):
N/A
4) Proposed maximum aggregate value of transaction:
N/A
5) Total fee paid:
N/A
[ ] Fee paid previously with preliminary materials.
[ ] Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which
the offsetting fee was paid previously. Identify the previous
filing by registration statement number, or the form or
schedule and the date of its filing.
1) Amount previously paid:
2) Form, Schedule or Registration Statement no.:
3) Filing Party:
4) Date Filed:
PRELIMINARY COPY
CONSENT STATEMENT OF GOLDEN CYCLE, LLC
This Consent Solicitation Statement (the "Consent Statement") and the
accompanying form of written consent are furnished by Golden Cycle, LLC
("Cycle") in connection with its solicitation of written consents from the
holders of common stock, $0.001 par value per share, of Global Motorsport Group,
Inc. (the "Company") to take the following action without a meeting of the
stockholders, as permitted by Delaware law:
1. Remove all current members of the Company's Board of Directors
and any other person or persons (other than the persons elected
pursuant to this consent) elected or appointed to the Board of
Directors of the Company prior to the effective date of this
stockholder action in addition to or in lieu of any of such
individuals to fill any newly created directorship or vacancy on
the Board of Directors of the Company, or otherwise (the
"Director Removal Proposal");
2. Amend Article III, Sections 1 and 2 of the Bylaws of the Company
to set the number of directors on the Board of Directors at five
(the "Board Size Proposal");
3. Elect Aaron H. Brenner, Alexander Grass, Roger Grass, H. Irwin
Levy and George Lindemann (collectively the "Cycle Nominees" or
the "Nominees") as directors of the Company to fill the newly
created vacancies on the Board of Directors and to serve until
their respective successors are duly elected and qualified (the
"Director Election Proposal"); and
4. Repeal any Bylaws adopted by the Board of Directors since April
30, 1997, other than the Bylaws adopted by this consent (the
"Bylaw Proposal" and together with the Director Removal Proposal,
the Board Size Proposal and the Director Election Proposal, the
"Proposals").
Stockholders of the Company are being asked to express their consent to
the Proposals by MARKING, SIGNING and DATING the enclosed BLUE consent card and
returning it to Innisfree M&A Incorporated in accordance with the instructions
set forth below.
GOLDEN CYCLE, LLC RECOMMENDS THAT YOU CONSENT TO EACH OF THE PROPOSALS
This Consent Statement and the BLUE consent card are first being
furnished to stockholders on or about April 3, 1998.
3
SUMMARY OF CONSENT PROCEDURE
Cycle believes that the Proposals will become effective on the date
when the written consent of holders of a majority of the shares of the Company's
Common Stock outstanding on the record date as determined in accordance with
Delaware law (the "Record Date") is delivered to the Company, so long as such
consent is obtained within 60 days after the Record Date. Section 213(b) of the
Delaware General Corporation Law (the "DGCL") provides that the record date for
a consent solicitation shall be as established by the board of the directors of
the corporation or, if no record date is established, shall be the first date on
which a signed written consent is delivered to the corporation. In order to
facilitate prompt adoption of the Proposals, Cycle requests you to give your
consent by _________, 1998.
CYCLE RECOMMENDS THAT YOU CONSENT TO EACH OF THE PROPOSALS. YOUR
CONSENT IS IMPORTANT. PLEASE MARK, SIGN AND DATE THE ENCLOSED BLUE CONSENT CARD
AND RETURN IT IN THE ENCLOSED POSTAGE-PAID ENVELOPE PROMPTLY. FAILURE TO RETURN
YOUR CONSENT WILL HAVE THE SAME EFFECT AS VOTING AGAINST THE PROPOSALS.
Cycle has retained Innisfree M&A Incorporated ("Innisfree") to assist
in the solicitation. If your shares are held in your name, please mark, sign,
date and mail the enclosed BLUE consent card to Innisfree in the postage-paid
envelope provided. If your shares are held in the name of a brokerage firm, bank
nominee or other institution, you should receive a BLUE consent card and
envelope which should be used to give your instructions to the person
responsible for your account. Only that institution can execute a BLUE consent
card with respect to your shares and only upon receipt of specific instructions
from you. Cycle urges you to confirm in writing your instructions to the person
responsible for your account and to provide a copy of those instructions to
Cycle in care of Innisfree at the address set forth below so that Cycle will be
aware of all instructions given and can attempt to ensure that such instructions
are followed.
If you have any questions about executing your consent or require
assistance, please contact:
INNISFREE M&A INCORPORATED
501 Madison Avenue, 20th Floor
New York, NY 10022
Toll Free: (888) 750-5834
Banks and Brokers call collect: (212) 750-5833
4
CYCLE
Cycle is a Pennsylvania limited liability company in which Alexander
Grass ("Alexander Grass") and Roger L. Grass ("Roger Grass") are each 50%
members. Alexander Grass serves as President and Secretary of Cycle, and Roger
Grass is its Vice-President and Treasurer. As of the date of this Consent
Statement, Cycle owns an aggregate of 528,700 shares of the Company's Common
Stock (the "Common Stock"), representing approximately 10.4% of the Company's
5,077,442 shares currently outstanding, based on publicly available information
filed by the Company with the Securities and Exchange Commission. The business
address and the address of the principal executive offices of Cycle is 4025
Crooked Hill Road, Harrisburg, Pennsylvania 17110.
Additional information about Cycle, its nominees and members is set
forth under the heading "Certain Other Information Regarding Cycle and the Cycle
Nominees" and in Exhibit A attached to this Consent Statement.
BACKGROUND AND REASONS FOR THE CONSENT SOLICITATION
On March 23, 1998, Cycle sent a letter to Mr. Joseph Piazza, President
and Chief Executive Officer of the Company, stating that Cycle was prepared to
acquire the Company at a price of $18 per share. The letter further stated that
the terms of the offer, including the price, were subject to negotiation if
greater value could be demonstrated. The letter requested that the Company
provide Cycle with information about the Company for the purpose of completing a
due diligence review of the Company to determine whether there is greater value
in the Company. A copy of the letter to Mr. Piazza is attached as Exhibit B to
this Consent Statement.
Cycle believes that a sale of the Company is both necessary and
desirable in order to maximize the value which can be realized by the Company's
stockholders and that the $18 per share offered by Cycle is a fair price based
upon publicly available information.
Cycle seeks to replace the current Board of Directors with its own
Nominees, who intend to vote to redeem the "Poison Pill" and then conduct
negotiations with Cycle or other parties that by then may have indicated an
interest in acquiring the Company. Based on the information available to it,
Cycle believes that $18 per share is a fair price for the Company and is fully
prepared to acquire the Company through a negotiated merger agreement at this
amount. However, because the Nominees are committed to selling the Company on
the terms most advantageous to the stockholders and only for a price that
reflects the Company's underlying value, they will encourage competing offers in
order to maximize stockholder value. Based upon publicly available information
regarding the Company, Cycle believes that the redemption of the Poison Pill
would be the most effective means of ensuring that the highest price is obtained
in a sale of the Company.
Cycle believes that when a substantial offer is made to acquire the
Company, the stockholders rather than the Board should have the final word on
whether the offer is accepted. Today the Company's Preferred Shares Rights
Agreement or "Poison Pill" enables the Board to block a proposal to acquire
control of the Company even if the acquiror is prepared to implement that
proposal through a tender or exchange offer to the Company's stockholders,
without making the Company a party to the transaction. A description of the
Poison Pill, set forth as Item 1 of the Company's Registration Statement on Form
8-A, dated December 9, 1996, is attached hereto as Exhibit C. As a result of the
Poison Pill, potential buyers do not have the option of dealing directly with
stockholders if the Board opposes their acquisition proposals. If the Proposals
are approved, the Cycle Nominees would constitute the entire Board of Directors
and would thereby have the power to redeem the Poison Pill. The Nominees have
committed to redeem the Poison Pill on the conditions described above promptly
after their election to the Board of Directors of the Company.
5
Cycle believes that the redemption of the Poison Pill will not result
in the Company's being subject to coercive takeover tactics since the Company
continues to be subject to Section 203 of the DGCL (the "Business Combination
Statute"). The Business Combination Statute provides, in effect, that if any
person acquires beneficial ownership of 15% or more of the Company's outstanding
shares (thereby becoming an "Interested Stockholder"), the Interested
Stockholder may not engage in a business combination with the Company for three
years thereafter, subject to certain exceptions. Among the exceptions are (i)
the Board's prior approval of such acquisition, (ii) the acquisition of at least
85% of the Company's shares (subject to certain exclusions) in the transaction
in which such person becomes an Interested Stockholder and (iii) the approval of
such business combination by 66-2/3% of the outstanding stock not owned by the
Interested Stockholder.
THE FOREGOING IS A SUMMARY OF THE BUSINESS COMBINATION STATUTE AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE THERETO.
Cycle seeks the amendment of the Bylaws to set the number of directors
on the Company's Board of Directors at five. The Bylaws currently authorize
between three and five directors. The number may be changed from time to time
within these limits by resolution of the Board. The current number of directors
authorized is uncertain. In the Company's Annual Report on Form 10-K for the
Year Ended January 31, 1997, five individuals are listed as directors. However,
a press release by the Company dated November 6, 1997 refers to Ignatius
("Nace") J. Panzica as "Chairman Emeritus." It is not clear whether, after
leaving his position as an employee of the Company, Mr. Panzica also gave up his
position as a director of the Company. In addition, a press report dated October
30, 1997 referring to the acquisition by the Company of Chrome Specialties, Inc.
("Chrome Specialties") states that Chrome Specialties was founded by brothers
Greg and John Kuelbs, who will remain with the company as board members and
consultants. Cycle believes that report is ambiguous as to whether Messrs. Greg
and John Kuelbs are directors of the Company or its wholly owned subsidiary
Chrome Specialties. Cycle's Board Size Proposal will set the size of the Board
at five directors, which vacancies will be filled by the Cycle Nominees pursuant
to the Director Election Proposal.
Cycle also seeks the repeal of any Bylaws adopted by the Board since
April 30, 1997 (the date of the Company's Annual Report on Form 10-K for the
fiscal year ended January 31, 1997, which incorporates by reference the form of
the Company's Bylaws) so that the Board cannot use new Bylaws to prevent the
stockholders from accomplishing the objectives described in this Consent
Statement.
Cycle believes that passage of the Director Removal Proposal, the Board
Size Proposal, the Director Election Proposal and the Bylaw Proposal is
necessary to facilitate the sale of the Company for a price that fully reflects
its underlying value. If elected, the Cycle Nominees for the Board of Directors
will pursue the sale of the Company to the highest bidder. The replacement of
the current Board with the Cycle Nominees will stimulate a competitive bidding
process, resulting in a sale of the Company (to Cycle or to another potential
bidder for a higher price than the $18 per share offered by Cycle) which
maximizes stockholder value. Accordingly, Cycle urges you to vote FOR these
Proposals.
THE PROPOSALS
This solicitation statement and the accompanying form of written
consent are first being furnished by Cycle on or about April 3, 1998, in
connection with the solicitation by Cycle from the holders of shares of Common
Stock of written consents to take the following actions without a stockholders
meeting, as permitted by Delaware law:
1. Remove the existing directors on the Board of Directors:
"RESOLVED, that each member of the Board of Directors of the Company,
and any other person or persons (other than the persons elected
6
pursuant to this consent) elected or appointed to the Board of
Directors of the Company prior to the effective date of this
resolution in addition to or in lieu of any of the aforenamed
individuals to fill any newly created directorship or vacancy on the
Board of Directors of the Company, or otherwise, is hereby removed and
the office of each member of the Board of Directors is hereby declared
vacant.";
2. Amend the Bylaws to set the number of directors at five:
"RESOLVED, that the stockholders hereby amend Article III of the
Bylaws by deleting Section 1 and by replacing it with a new Section 1,
which shall read as follows:
'The authorized number of directors of this corporation shall be
five (5). Except as provided in Section 2 of this Article, the
directors shall be elected at the annual meeting of the
stockholders, in accordance with the certificate of
incorporation, and each director elected shall hold office until
his or her successor is elected and qualified, unless he or she
shall resign, become disqualified, disabled or otherwise removed.
Directors need not be stockholders.'; and
RESOLVED, that the stockholders hereby amend Article III of the Bylaws
by deleting the first sentence of Section 2 and by replacing it with a
new first sentence, which shall read as follows:
'Vacancies may be filled by a majority of the directors then in
office, though less than a quorum, by a sole remaining director,
or by a vote of the stockholders at an annual or special meeting
of the stockholders or by written consent in lieu of a meeting of
stockholders, and the directors so chosen shall hold office until
the next annual election and until their successors are duly
elected and shall qualify, unless sooner displaced.'";
3. Elect the five persons listed below to fill the newly vacant
directorships:
"RESOLVED, that the following persons are hereby elected as directors
of the Company to fill the newly created vacancies on the Board of
Directors, and to serve until their respective successors are duly
elected and qualified: Aaron H. Brenner, Alexander Grass, Roger Grass,
H. Irwin Levy, George Lindemann."; and
4. Repeal any Bylaws adopted by the Board of Directors since April 30,
1997:
"RESOLVED, that any amendments to the Bylaws of the Company adopted by
the Board of Directors of the Company on or after April 30, 1997 and
prior to the effective date of this resolution (other than the Bylaws
adopted pursuant to this consent), are hereby rescinded and shall have
no further force or effect."
See Exhibit A and the next section for more information about the Cycle
Nominees. Cycle proposes that the nominees named above, once elected, serve
until the next annual meeting of the stockholders and until their successors
have been duly elected and qualified. Each of the Cycle Nominees has consented
to serve as a director of the Company if elected.
7
CERTAIN OTHER INFORMATION REGARDING CYCLE AND
THE CYCLE NOMINEES
The following sets forth information about the Cycle Nominees:
Name & Address Principal Occupation and Five-Year Employment History
-------------- ------------------------------------------------------
Alexander Grass Alexander Grass' principal occupation has been as a
c/o Biker's Depot, Inc. director, Honorary Chairman of the Board of Directors and
One Wynnewood Road Chairman of the Executive Committee of the Board of Directors
Wynnewood, PA 19096 of Rite Aid Corporation since March 4, 1995. Prior to that time, he served
as Rite Aid's Board Chairman and Chief Executive Officer. Alexander Grass is
also a director of Hasbro, Inc. and the father of Roger Grass. His age is 70.
Roger Grass Roger Grass' principal occupation since 1994 has been as
c/o Biker's Depot, Inc. Chairman of the Board of Directors of Biker's Depot, Inc.
One Wynnewood Road ("Biker's Depot"), a company engaged in the sale of
Wynnewood, PA 19096 aftermarket parts and accessories for Harley-Davidson motorcycles. From
1989 through 1993 he was the President and Chief Executive Officer of Reliable
Drug, Inc. His age is 42.
George Lindemann During the last five years, George Lindemann has served as
c/o Southern Union Co. Chairman of the Board of Directors of Southern Union
504 Lavaca Street Company, a gas utility company whose stock is listed on
Austin, TX 78701 the New York Stock Exchange. His age is 62.
H. Irwin Levy H. Irwin Levy presently serves as President and Chairman
100 Century Blvd. of the Board of Directors of Hilcoast Development Corp.,
W. Palm Beach, FL 33417 a real estate developer, which position he has held since
August 1992. Mr. Levy also serves on the Board of
Directors of CV Reit, Inc. and nStor Technologies, Inc.
His age is 71.
Aaron H. Brenner At present, Aaron H. Brenner is a private investor.
1609 Appletree Road From April, 1993 to the present, Mr. Brenner has served as
Harrisburg, PA 17110 managing partner of ABH Partners, a real estate joint venture.
Prior to April, 1993, Mr. Brenner served as President of
M. Brenner & Sons, Inc., a wholesale drug, candy and tobacco
distributor. His age is 66.
Of the five Nominees, except as set forth in this Consent Statement or
in the Exhibits hereto, to the best knowledge of Cycle, none is employed by or
affiliated with Cycle or Alexander Grass or Roger Grass. All of the Nominees are
citizens of the United States.
Roger Grass is Chairman of the Board of Directors of Biker's Depot, a
retail seller of aftermarket parts and accessories for Harley-Davidson
motorcycles. The Company is a major wholesale supplier of parts and accessories
to Biker's Depot. All indebtedness of Biker's Depot to the Company since the
beginning of the Company's last fiscal year is ordinary course of business
purchase order indebtedness. During the period from February 1997 through
January 1998 (which period corresponds to the Company's last fiscal year),
Biker's Depot made purchases from the Company in the amount of $222,712.
Except as set forth in this Consent Statement or in the Exhibits
hereto, to the best knowledge of Cycle, none of Cycle, any of the persons
participating in this solicitation on behalf of Cycle, the Cycle Nominees, and
any associate or immediate family member of the foregoing persons (i) owns
beneficially, directly or indirectly, or has the right to acquire, any
securities of the Company or any parent or subsidiary of the Company, (ii) owns
any securities of the Company
8
of record but not beneficially, (iii) has purchased or sold any securities of
the Company within the past two years, (iv) has incurred indebtedness for the
purpose of acquiring or holding securities of the Company, (v) is or has been a
party to any contract, arrangement or understanding with respect to any
securities of the Company within the past year, (vi) has been indebted to the
Company or any of its subsidiaries since the beginning of the Company's last
fiscal year or (vii) has any arrangement or understanding with respect to future
employment by the Company or with respect to any future transactions to which
the Company or any of its affiliates will or may be a party. In addition, except
as set forth in this Consent Statement or in the Exhibits hereto, to the best
knowledge of Cycle, none of Cycle, any of the persons participating in this
solicitation on behalf of Cycle, the Cycle Nominees, and any associate or
immediate family member of any of the foregoing persons has had or is to have a
direct or indirect material interest in any transaction with the Company since
the beginning of the Company's last fiscal year, or any proposed transaction, to
which the Company or any of its affiliates was or is a party.
Except as set forth in this Consent Statement or in the Exhibits
hereto, to the best knowledge of Cycle, none of the Nominees, since the
beginning of the Company's last fiscal year, has been affiliated with (i) any
entity that made or received, or during the Company's current fiscal year
proposes to make or receive, payments to or from the Company or its subsidiaries
for property or services in excess of five percent of either the Company's or
such entity's consolidated gross revenues for its last full fiscal year, or (ii)
any entity to which the Company or its subsidiaries was indebted at the end of
the Company's last full fiscal year in an aggregate amount exceeding five
percent of the Company's total consolidated assets at the end of such year. None
of the Nominees is or during the Company's last fiscal year has been affiliated
with any law or investment banking firm that has performed or proposes to
perform services for the Company.
None of the corporations or organizations in which the Cycle Nominees
have conducted their principal occupation or employment was a parent, subsidiary
or other affiliate of the Company, and the Nominees do not hold any position or
office with the Company or have any family relationship with any executive
officer or director of the Company or have been involved in any proceedings,
legal or otherwise, of the type required to be disclosed by the rules governing
this solicitation.
Cycle has agreed to indemnify each of the Nominees against all
liabilities, including liabilities under the federal securities laws, in
connection with this consent solicitation and such person's involvement in the
operation of the Company and to reimburse such Nominee for his out-of-pocket
expenses.
Part of the purchase price paid by Cycle in connection with its
acquisition of Common Stock of the Company was financed by margin loans made by
brokerage firms in the ordinary course of business and borrowings from Dauphin
Deposit Bank and Trust Company (the "Bank") under an unsecured loan note bearing
interest at the Federal Funds Target Rate plus 90 basis points. As of March 24,
1998, Cycle was indebted to the Bank in the amount of approximately $7.1
million.
The accompanying BLUE consent card will be voted in accordance with the
stockholder's instruction on such BLUE consent card. As to the Proposals set
forth herein, stockholders may consent to an entire Proposal or may withhold
their consent by marking the proper box in the BLUE consent card. If the
enclosed BLUE consent card is signed and returned and no direction is given, it
will be deemed to constitute consent to all of the Proposals.
CERTAIN OTHER INFORMATION REGARDING THE CONSENT SOLICITATION
Cycle seeks the consent of an absolute majority of the Company's issued
and outstanding stock in order to act on the Proposals set forth in this Consent
Statement.
BROKER NON-VOTES, ABSTENTIONS AND FAILURE TO RETURN A SIGNED CONSENT
WILL HAVE THE SAME EFFECT AS WITHHOLDING CONSENT TO THE PROPOSAL.
9
Change of Control
Pursuant to the Company's various stock option plans, the Director
Removal and Director Election Proposals, if adopted by the stockholders of the
Company, would cause certain options to purchase Common Stock, which options
were granted by the Company to its employees, directors and consultants, to
become immediately exercisable. As of January 31, 1997, the Company had 863,230
options outstanding at a weighted exercise price of $18.08 per share; an
additional 389,000 options were issued in 1997 at an exercise price of $18.13
per share.
Pursuant to the Company's 1997 Stock Option Plan, options and stock
purchase rights may be granted to employees, directors and consultants of the
Company. In the event of a change of control of the Company, for a period of 15
days following the optionee's notification by the administrator of the plan, the
optionee may exercise his or her options as to all of the optioned stock.
Because the 1997 Stock Option Plan is not publicly available as of the date of
this consent solicitation, the information herein is based on the plan summary
contained in the Company's 1997 Proxy Statement and is qualified in its entirety
by reference thereto.
Pursuant to the Company's 1995 Stock Option Plan, options granted under
the plan that are held by non-employee directors will be "accelerated", or
become immediately exercisable, for all the option shares in the event of a
change in control of the Company, whether through a successful tender offer for
more than 50% of the outstanding Common Stock or a change in the majority of the
Board of Directors by one or more proxy contests. The plan administrator has
discretionary authority, exercisable in advance of any actually-anticipated
change in control or at the time of such change in control, to provide for the
automatic acceleration of one or more options held by key employees, consultants
and independent contractors (and the termination of one or more of the Company's
outstanding repurchase rights with respect to Common Stock acquired through the
exercise of such options) upon the occurrence of the change in control.
Additionally, in the case of an optionee whose service with the Company is
terminated, the administrator may permit exercise of the optionee's options,
within a limited time period, with respect to subsequent installments of
purchasable shares for which the options would otherwise have become exercisable
had such cessation of service not occurred. The 1995 Stock Option Plan is
attached as an exhibit to the Company's Registration Statement on Form S-8,
filed with the Securities and Exchange Commission on December 6, 1995, and this
description is qualified in its entirety by reference thereto
The material provisions of the Company's 1991 Stock Option Plan, as
restated on March 2, 1992, are substantially identical to those in the 1995
Stock Option Plan. The 1991 Stock Option Plan is attached as an exhibit to the
Company's Registration Statement on Form S-8, filed on April 16, 1992, and this
description is qualified in its entirety by reference thereto.
Additionally, the Company, in connection with its 1997 acquisition of
the assets of Chrome Specialties, entered into a $73.5 million credit agreement
with Bank of America National Trust and Savings Association ("Bank of America").
While the credit agreement is not publicly available as of the date of this
consent solicitation, it is possible that the removal and replacement of a
majority of the Board of Directors of the Company could constitute an event
permitting Bank of America to cancel its obligations to make loans to the
Company and/or to declare the outstanding principal amount of, and the interest
accrued on, the existing loans due and payable.
Consents Required
The written consent of an absolute majority of the outstanding Common
Stock is required to adopt and approve each of the Proposals. To the knowledge
of Cycle, there were 5,077,442 shares of Common Stock outstanding at October 31,
1997, based on the Company's Quarterly Report on Form 10-Q for the Three-Month
Period Ended October 31, 1997. Each share of Common Stock entitles the Record
Date holder to one vote on each of the Proposals. Accordingly, based on the
information known to Cycle, written consents by holders representing 2,538,722
shares of Common Stock will be required to adopt and approve each of the
Proposals. Each
10
abstention and broker non-vote with respect to any of the Proposals will have
the same effect as withholding consent to the adoption of such Proposal.
Special Instructions
If you were a record holder as of the close of business on the Record
Date, you may elect to consent to, withhold consent or abstain with respect to
each Proposal by marking the "CONSENT", "CONSENT WITHHELD" or "ABSTAIN" box, as
applicable, underneath each such Proposal on the accompanying BLUE consent card
and signing, dating and returning it promptly in the enclosed postage-paid
envelope.
IF THE STOCKHOLDER WHO HAS EXECUTED AND RETURNED THE CONSENT CARD HAS
FAILED TO CHECK A BOX MARKED "CONSENT", "CONSENT WITHHELD" OR "ABSTAIN" FOR ANY
OR ALL OF THE PROPOSALS, SUCH STOCKHOLDER WILL BE DEEMED TO HAVE CONSENTED TO
SUCH PROPOSAL OR PROPOSALS.
CYCLE RECOMMENDS THAT YOU CONSENT TO EACH OF THE PROPOSALS. YOUR
CONSENT IS IMPORTANT. PLEASE MARK, SIGN AND DATE THE ENCLOSED BLUE CONSENT CARD
AND RETURN IT IN THE ENCLOSED POSTAGE-PAID ENVELOPE PROMPTLY. FAILURE TO RETURN
YOUR CONSENT WILL HAVE THE SAME EFFECT AS WITHHOLDING CONSENT TO THE PROPOSALS.
If your shares are held in the name of a brokerage firm, bank nominee
or other institution, you should contact the person responsible for your account
and give instructions for the BLUE consent card representing your shares to be
mailed, dated and signed. Only that institution can execute a BLUE consent card
with respect to your shares and only upon receipt of specific instructions from
you. Cycle urges you to confirm in writing your instructions to the person
responsible for your account and to provide a copy of those instructions to
Cycle in care of Innisfree at the address set forth below so that Cycle will be
aware of all instructions given and can attempt to ensure that such instructions
are followed.
THE CONSENT PROCEDURE
Section 228 of the DGCL states that, unless otherwise provided in the
certificate of incorporation, any action that may be taken at any annual or
special meeting of stockholders may be taken without a meeting, without prior
notice and without a vote, if consents in writing, setting forth the action so
taken, shall be signed by the holders of outstanding stock having not less than
the minimum number of votes that would be necessary to authorize or take such
action at a meeting at which all shares entitled to vote thereon were present
and voted, and those consents were delivered to the corporation by delivery to
its registered office in Delaware, its principal place of business or an officer
or agent of the corporation having custody of the book in which proceedings of
meetings of stockholders are recorded. In the case of this Consent Solicitation,
written, unrevoked consents of the holders of a majority of the outstanding
shares of Common Stock as of the Record Date must be delivered to the Company as
described above to effect the actions as to which consents are being solicited
hereunder. Section 228 of the DGCL further provides that no written consent
shall be effective to take the corporate action referred to therein unless,
within 60 days of the earliest dated consent delivered in the manner required by
Section 228, written consents signed by a sufficient number of holders to take
such action are delivered to the corporation in the manner required by Section
228. In order to facilitate prompt adoption of the Proposals, Cycle requests
that you give your consent by _____, 1998.
IT IS CURRENTLY THE INTENTION OF CYCLE TO CEASE THE SOLICITATION OF
CONSENTS ONCE THE SOLICITOR HAS DETERMINED THAT VALID AND UNREVOKED CONSENTS
REPRESENTING A MAJORITY OF THE ISSUED AND OUTSTANDING SHARES OF COMMON STOCK
11
AS OF THE RECORD DATE HAVE BEEN OBTAINED AND TO DELIVER SUCH CONSENTS TO THE
COMPANY IN THE MANNER REQUIRED BY SECTION 228 OF THE DGCL AS SOON AS PRACTICABLE
THEREAFTER. WHEN CONSENTS FOR A MAJORITY OF THE COMPANY'S COMMON STOCK HAVE BEEN
OBTAINED AND DELIVERED TO THE COMPANY, A STOCKHOLDER WILL BE UNABLE TO REVOKE
HIS OR HER CONSENT.
If the actions described herein are taken, the Company will promptly
notify the stockholders who have not consented to the actions taken as required
by the DGCL.
Consents may only be executed by stockholders of record at the close of
business on the Record Date. As of October 31, 1997, the Company had outstanding
5,077,442 shares of Common Stock. The number of votes necessary to effect the
Proposals is 2,538,722 (an absolute majority of 5,077,442).
Based on its review of publicly available information, Cycle is not
aware of any material change since the Record Date in the number of outstanding
shares of Common Stock. Each share of Common Stock entitles the record holder
thereof to cast one vote. The Company's Certificate of Incorporation and Bylaws
do not provide for cumulative voting.
Since Cycle must receive consents from a majority of the Company's
outstanding shares in order for the Proposals to be adopted, a broker non-vote
or direction to withhold authority to vote on the BLUE card will have the same
effect as a "no" vote with respect to Cycle's solicitation.
BROKER NON-VOTES, ABSTENTIONS OR FAILURE TO RETURN A SIGNED CONSENT
WILL HAVE THE SAME EFFECT AS WITHHOLDING CONSENT TO THE PROPOSALS. CYCLE URGES
EACH STOCKHOLDER TO ENSURE THAT THE RECORD HOLDER OF HIS OR HER SHARES MARKS,
SIGNS, DATES AND RETURNS THE ENCLOSED CONSENT AS SOON AS POSSIBLE.
CERTAIN OTHER INFORMATION REGARDING THE COMPANY
Stockholders are referred to the Company's 1997 Proxy Statement with
respect to the compensation and remuneration paid and payable and other
information related to the Company's officers and directors and to the
beneficial ownership of the Company's securities.
VOTING; COSTS OF CONSENT SOLICITATION
Written consents may be solicited by mail, advertisement, telephone,
facsimile or in person. Solicitations may be made by officers of Cycle; however,
no such person shall receive additional compensation for such solicitation other
than Innisfree. Cycle has retained Innisfree to act as an advisor in the
submission of this consent solicitation. Approximately 20 employees of Innisfree
will engage in the solicitation. Cycle has agreed to pay Innisfree a fee
estimated not to exceed $25,000 plus reasonable out-of pocket expenses. In
addition, Jefferies & Company, Inc. ("Jefferies") has been engaged to act as
financial advisor to Cycle and its Members in connection with a possible
acquisition of the Company, including any financing or investment activities
which may be undertaken in connection therewith (the "Engagement Agreement").
The Engagement Agreement provides, among other things, that in payment for
services to be rendered by Jefferies, if within twelve months from the date of
the Engagement Agreement any shares of Common Stock owned by Cycle or any of its
affiliates are sold to any person, Jefferies will be paid a fee equal to 15% of
the profit in respect of such sale.
Cycle anticipates that a total of approximately $50,000 will
be spent in connection with the solicitation. Actual expenditures may vary
materially from the estimate, however, as many expenditures cannot be readily
predicted. To date, expenses of approximately $25,000 have been incurred in
connection with the
12
solicitation. The entire expense of preparing, assembling, printing and mailing
this Consent Statement and any other consent soliciting materials and the cost
of soliciting consents will initially be borne by Cycle. If the Cycle Nominees
are elected, Cycle intends to request reimbursement from the Company for these
expenses. This request will not be submitted to a stockholder vote. Banks,
brokerage houses and other custodians, nominees and fiduciaries may be requested
to forward Cycle's solicitation materials to the beneficial owners of the shares
they hold of record, and Cycle will reimburse them for their reasonable
out-of-pocket expenses.
If your shares are registered in your own name, you may mail or fax
your consent to Cycle at the address or fax number listed below.
If your shares are held in "street name" (held by your brokerage firm
or bank), immediately instruct your broker or bank representative to sign
Cycle's BLUE consent card and mail it to Cycle, who will promptly deliver it.
Please be certain to include the name of your brokerage firm or bank. If you
have additional questions, please call:
Innisfree M&A Incorporated
501 Madison Avenue, 20th Floor
New York, NY 10022
Call Toll-Free: (888) 750-5834
Banks and Brokers call collect: (212) 750-5833
A consent executed by a stockholder may be revoked at any time before
its exercise by submitting (i) a written, dated revocation of such consent or
(ii) a later dated consent covering the same shares. A revocation may be in any
written form validly signed by the record holder as long as it clearly states
that the consent previously given is no longer effective and must be executed
and delivered prior to the time that the action authorized by the executed
consent is taken. The revocation may be delivered to Golden Cycle, LLC, c/o
Innisfree M&A Incorporated, 501 Madison Avenue, 20th Floor, New York, NY 10022,
Attn.: Alan M. Miller. Although a revocation or later dated consent delivered
only to the Company will be effective to revoke a previously executed consent,
Cycle requests that if a revocation or later dated consent is delivered to the
Company, a photocopy of the revocation or later dated consent also be delivered
to Cycle, at the address set forth above, so that Cycle will be aware of such
revocation.
YOUR CONSENT IS IMPORTANT. NO MATTER HOW MANY OR HOW FEW SHARES YOU
OWN, PLEASE CONSENT TO THE REMOVAL OF THE CURRENT BOARD OF DIRECTORS, THE
AMENDMENT OF THE BYLAWS TO SET THE NUMBER OF DIRECTORS, THE ELECTION OF THE
CYCLE NOMINEES AND THE REPEAL OF ANY BYLAWS ADOPTED SINCE APRIL 30, 1997 BY
MARKING, SIGNING, DATING AND MAILING THE ENCLOSED BLUE CONSENT CARD PROMPTLY.
ONLY YOUR LATEST DATED CONSENT COUNTS.
13
EXHIBIT A
Golden Cycle, LLC is the beneficial owner of 528,700 shares of the
Common Stock. None of the other participants in this consent soliciation or
their respective associates, including the Cycle Nominees, is the beneficial
owner of any shares of the Common Stock. No shares are held of record but not
beneficially by the participants or their associates.
The following table sets forth information with respect to all
purchases of Common Stock of the Company by Cycle during the past two years.
(Except as set forth below, no participant in this solicitation has purchased or
sold securities of the Company within the past two years.)
Shares Purchased by Golden Cycle, LLC
Date Number of Shares Purchased Price
1/20/98 24,000 $283,200
1/20/98 1,000 11,675
1/21/98 5,000 61,500
1/21/98 7,000 84,350
1/21/98 2,000 23,600
1/22/98 3,000 36,525
1/27/98 50,000 615,000
1/28/98 25,000 307,500
1/29/98 5,000 62,125
2/02/98 3,000 37,275
2/03/98 10,000 126,750
2/03/98 5,000 62,750
2/04/98 2,500 31,375
2/09/98 20,000 273,500
2/10/98 2,000 27,100
2/13/98 20,000 276,000
2/13/98 20,000 273,500
2/19/98 20,000 276,000
2/20/98 10,600 146,280
2/20/98 10,000 136,750
3/12/98 50,000 677,500
3/13/98 50,000 690,000
3/17/98 125,000 1,718,750
3/19/98 58,000 870,000
14
EXHIBIT B
GOLDEN CYCLE, LLC
4025 Crooked Hill Road
Harrisburg, Pennsylvania 17110
March 23, 1998
Mr. Joseph Piazza
President and Chief Executive Officer
Global Motorsport Group, Inc.
16100 Jacqueline Court
Morgan Hill, California 95037
Dear Mr. Piazza:
Golden Cycle, LLC is prepared to acquire Golden Motorsport Group, Inc.
for a cash purchase price of $18 per share. Based upon our review of publicly
available information, we believe the $18 price is a full and fair one. Our
offer is subject to negotiation of a definitive merger agreement which would
contain customary terms and conditions. Our financial advisor, Jefferies &
Company, Inc., has advised us that they are highly confident in their ability to
arrange the financing for our cash acquisition of the company. We would very
much appreciate the opportunity to negotiate all terms of a transaction,
including the price, with you and your Board of Directors.
Wholly apart from our willingness to negotiate all aspects of a
possible offer based on what we know about Global Motorsport Group today, we
also recognize that there may be values inherent in the company which we are
unable to perceive without access to nonpublic information and the assistance of
you and your management team. Accordingly, we would request that any pertinent
information which is available to your management or is made available to your
investment bankers or third parties for the purpose of evaluating or pursuing
alternative transactions be made available to us as well, so that any offer and
its terms may be formulated with the full benefit of a level and illuminated
playing field. We would naturally agree to execute a customary confidentiality
agreement with respect to the confidential information supplied to us.
While we are committed to working with you and your Board of Directors
and pursuing a negotiated transaction, we also believe that if you and your
Board of Directors do not wish to proceed with negotiations or to provide us
with an opportunity to conduct due diligence so that we can determine if there
is greater value in the company, we will consider attempting to seek control of
the Board of Directors through a consent solicitation which would elect
directors committed to selling the company for the highest price reasonably
available. In view of the possibility that the Board might seek to erect
non-economic obstacles or impediments which prevent stockholders from having a
fair opportunity to consider and respond to any offer we might make, we will be
filing preliminary proxy materials with the Securities and Exchange Commission
with respect to such a consent solicitation. We certainly hope that, consistent
with its fiduciary responsibilities, the Board will not take such actions which
would require us to pursue the proxy contest.
We are filing a statement on Schedule 13D with the Securities and
Exchange Commission today announcing our acquisition of approximately 10.4% of
the outstanding Global Motorsport Group's shares.
We and our advisors are prepared to meet promptly with the company's
directors, management and advisors (or designated representatives) at their
convenience in order to negotiate a mutually desirable and beneficial
transaction.
15
We look forward to hearing from you at your earliest convenience.
Very truly yours,
/s/ Alex Grass
--------------------
16
EXHIBIT C
PREFERRED SHARE PURCHASE RIGHTS
On November 13, 1996, pursuant to a Preferred Shares Rights Agreement
(the "Rights Agreement") between Custom Chrome, Inc. (the "Company") and
American Stock Transfer and Trust Company, as Rights Agent (the "Rights Agent"),
the Company's Board of Directors declared a dividend of one right (a "Right") to
purchase one one-thousandth of a share of the Company's Series A Participating
Preferred Stock, $0.001 par value ("Series A Preferred") for each outstanding
share of Common Stock, $0.001 par value ("Common Shares"), of the Company. The
dividend is payable on December 13, 1996 (the "Record Date") to stockholders of
record as of the close of business on that date. Each Right entitles the
registered holder to purchase from the Company one one-thousandth of a share of
Series A Preferred at an exercise price of $80.00 (the "Purchase Price"),
subject to adjustment as provided for in the Rights Agreement.
The following summary of the principal terms of the Rights Agreement is
a general description only and is subject to the more detailed terms and
conditions of the Rights Agreement. A copy of the Rights Agreement is attached
as Exhibit 4 to this Registration Statement and is incorporated herein by
reference.
Rights Evidenced by Common Share Certificates
The Rights will not be exercisable until the Distribution Date
(hereinafter defined). Certificates for the Rights ("Rights Certificates") will
not be sent to stockholders and the Rights will attach to and trade only
together with the Common Shares. Accordingly, Common Share certificates
outstanding on the Record Date will evidence the Rights related thereto, and
Common Share certificates issued after the Record Date will contain a legend
incorporating the Rights Agreement by reference. Until the Distribution Date (or
earlier redemption or expiration of the Rights), the surrender or transfer of
any certificates for Common Shares, outstanding as of the Record Date, even
without notation or a copy of the Summary of Rights being attached thereto, will
also constitute the transfer of the Rights associated with the Common Shares
represented by such certificate. The Rights will be transferable only in
connection with the transfer of Common Shares prior to the Distribution Date.
Distribution Date
The Rights will separate from the Common Shares, Rights Certificates
will be issued and the Rights will become exercisable upon the earlier of: (i)
10 days (or such later date as may be determined by a majority of the Board of
Directors, excluding directors affiliated with the Acquiring Person, as defined
below (the "Continuing Directors")) following a public announcement that a
person or group of affiliated or associated persons (an "Acquiring Person") has
acquired beneficial ownership of 15% or more of the outstanding Common Shares,
including Common Shares held by affiliates or associates of the Acquiring
Person, or (ii) 10 business days (or such later date as may be determined by a
majority of the Continuing Directors then in office) following the commencement
of, or announcement of an intention to make, a tender offer or exchange offer
the consummation of which would result in the beneficial ownership by a person
or group of 15% or more of the outstanding Common Shares.
Issuance of Rights Certificates; Expiration of Rights
As soon as practicable following the Distribution Date, separate Rights
Certificates will be mailed to holders of record of the Common Shares as of the
close of business on the Distribution Date and such separate Rights Certificates
alone will evidence the Rights from and after the Distribution Date. All Common
Shares issued prior to the Distribution Date will be issued with Rights. As of
the Distribution Date, the Rights will be evidenced solely by the Rights
Certificates and may be transferred separately and apart from any transfer of
one or more Common Shares. In general, Rights will be issued in respect of all
Common Shares issued after the Record Date but prior to the earlier of the
Distribution Date or Final Expiration Date (as hereinafter defined), unless the
Board of
17
Directors specifies to the contrary at or before the time of the issuance of the
Common Shares (including issuances of Common Shares pursuant to the exercise of
rights under the Company's benefit plans). The Rights will expire on the
earliest of (i) November 13, 2006 (the "Final Expiration Date") or (ii)
redemption or exchange of the Rights as described below.
Initial Exercise of the Rights
Following the Distribution Date, and until one of the further events
described below, holders of the Rights will be entitled to receive, upon
exercise and the payment of $80.00 per Right, one one-thousandth share of the
Series A Preferred.
Right to Buy Company Common Shares
Unless the Rights are earlier redeemed, in the event that an Acquiring
Person becomes the beneficial owner of 15% or more of the Company's Common
Shares then outstanding, then proper provision will be made so that each holder
of a Right which has not theretofore been exercised (other than Rights
beneficially owned by the Acquiring Person, which will thereafter be void) will
thereafter have the right to receive, upon exercise, Common Shares having a
value equal to two times the Purchase Price. In the event that the Company does
not have sufficient Common Shares available for all Rights to be exercised, or
the Board decides that such action is necessary or appropriate and not contrary
to the interests of Rights holders, the Company may instead reduce the Purchase
Price or substitute cash, assets or other securities having an aggregate value
equivalent to the excess of (i) the value of the Common Shares issuable upon
exercise of the Rights over (ii) the Purchase Price to be paid upon exercise of
the Rights. Rights are not exercisable following the occurrence of an event as
described above until such time as the Rights are no longer redeemable by the
Company as set forth below.
Right to Buy Acquiring Company Stock
Similarly, unless the Rights are earlier redeemed, in the event that,
after an Acquiring Person becomes the beneficial owner of 15% or more of the
Company's Common Shares then outstanding, (i) the Company is acquired in a
merger or other business combination transaction (whether or not the Company is
the surviving entity), or (ii) 50% or more of the Company's consolidated assets
or earning power are sold, proper provision must be made so that each holder of
a Right which has not theretofore been exercised (other than Rights beneficially
owned by the Acquiring Person, which will thereafter be void) will thereafter
have the right to receive, upon exercise, shares of common stock (free of any
restrictions) of the acquiring company having a value equal to two times the
Purchase Price.
Exchange Provision
At any time after the acquisition by an Acquiring Person of 15% or more
of the Company's outstanding Common Shares and prior to the acquisition by such
Acquiring Person of 50% or more of the Company's outstanding Common Shares, the
Board of Directors of the Company may exchange the Rights (other than Rights
owned by the Acquiring Person), in whole or in part, at an exchange ratio of one
Common Share per Right.
Redemption
At any time on or prior to the close of business on the earlier of (i)
the 10th day following the first public announcement by the Company or Acquiring
Person that the Acquiring Person has become such (the "Share Acquisition Date")
or such later date as may be determined by a majority of the Continuing
Directors and publicly announced by the Company, or (ii) the Final Expiration
Date of the Rights, the Company may redeem the Rights in whole, but not in part,
at a price of $0.01 per Right (the "Redemption Price"). The Company may, at its
option, pay
18
the Redemption Price either in Common Shares or cash. If the Board of Directors
authorizes the redemption of the Rights after a person becomes an Acquiring
Person, then a majority of the Continuing Directors are required to authorize
the redemption of the rights. Immediately upon action by the Board of Directors
redeeming the Rights as described above, the Rights will terminate and the only
right thereafter of the holders of Rights is to receive the Redemption Price.
Adjustments to Prevent Dilution
The Purchase Price payable, the number of Rights, and the
number of Series A Preferred or Common Shares or other securities or property
issuable upon exercise of the Rights are subject to adjustment from time to time
in connection with dilutive issuances by the Company as set forth in the Rights
Agreement. With certain exceptions, no adjustment in the Purchase Price will be
required until cumulative adjustments require an adjustment of at least 1% in
such Purchase Price.
Cash Paid Instead of Issuing Fractional Shares
No fractional portion less than integral multiples of one Common Share
will be issued upon exercise of a Right and in lieu thereof, an adjustment in
cash will be made based on the market price of the Common Shares on the last
trading date prior to the date of exercise.
No Stockholders' Rights Prior to Exercise
Until a Right is exercised, the holder thereof, as such, will have no
rights as a stockholder of the Company (other than any rights resulting from
such stockholder's ownership of Common Shares), including, without limitation,
the right to vote or to receive dividends.
Amendment of Rights Agreement
The provisions of the Rights Agreement may be supplemented or amended
by the Board of Directors in any manner without the approval of the Rights
holders prior to the date on which the Rights are distributed separate from the
Common Shares. After such date, the provisions of the Rights Agreement may be
amended by the Board in order to cure any ambiguity, defect or inconsistency, to
make changes which do not adversely affect the interests of holders of Rights
(excluding the interests of any Acquiring Person), or to shorten or lengthen any
time period under the Rights Agreement; provided, however, that no amendment to
adjust the time period governing redemption shall be made at such time as the
Rights are not redeemable.
Rights and Preferences of the Series A Preferred
Series A Preferred purchasable upon exercise of the Rights will not be
redeemable. Each share of Series A Preferred will be entitled to an aggregate
dividend of 1,000 times the aggregate per share amount of all dividends declared
(including noncash dividends and other distributions) per Common Share. In the
event of liquidation, the holders of each share of Series A Preferred will be
entitled to receive 1,000 times the per share consideration being distributed
with respect to each Common Share plus an amount equal to accrued and unpaid
dividends and distributions thereon, whether or not declared, to the date of
such payment. Each share of Series A Preferred will have 1,000 votes, voting
together with the Common Shares. These rights are protected by certain
anti-dilution provisions, including a proportional adjustment to the number of
outstanding shares of Series A Preferred in the event the Company (i) declares a
dividend on Common Shares payable in Common Shares, (ii) subdivides the
outstanding Common Shares, or (iii) combines the outstanding Common Shares into
a smaller number of shares.
19
Because of the nature of the dividend, liquidation and voting rights of
the shares of Series A Preferred, the value of the one one-thousandth interest
in a share of Series A Preferred purchasable upon exercise of each Right should
approximate the value of one Common Share.
Certain Anti-takeover Effects
The Rights approved by the Board are designed to protect and maximize
the value of the outstanding equity interests in the Company in the event of an
unsolicited attempt by an acquiror to take over the Company, in a manner or on
terms not approved by the Board of Directors. Takeover attempts frequently
include coercive tactics to deprive the Company's Board of Directors and its
stockholders of any real opportunity to determine the destiny of the Company.
The Rights have been declared by the Board in order to deter such tactics,
including a gradual accumulation of shares in the open market of a 15% or
greater position to be followed by a merger or a partial or two-tier tender
offer that does not treat all stockholders equally. These tactics unfairly
pressure stockholders into making ill-advised investment decisions, squeeze them
out of their investment without giving them any real choice and deprive them of
the full value of their equity interest.
The Rights are not intended to prevent a takeover of the Company and
will not do so. The Rights may be redeemed by the Company at $0.01 per Right
within ten days (or such later date as may be determined by a majority of the
Continuing Directors) after the public announcement that 15% or more of the
Company's shares have been acquired by a single acquiror or group. Accordingly,
the Rights should not interfere with any merger or business combination approved
by the Board of Directors.
Issuance of the Rights does not in any way weaken the financial
strength of the Company or interfere with its business plans. The issuance of
the Rights themselves has no dilutive effect, will not affect reported earnings
per share, should not be taxable to the Company or to its stockholders, and will
not change the way in which the Company's shares are presently traded. The
Company's Board of Directors believes that the Rights represent a sound and
reasonable means of addressing the complex issues of corporate policy created by
the current takeover environment.
However, the Rights may have the effect of rendering more difficult or
discouraging an acquisition of the Company deemed undesirable by the Board of
Directors. The Rights may cause substantial dilution to a person or group that
attempts to acquire the Company on terms or in a manner not approved by the
Company's Board of Directors, except pursuant to an offer conditioned upon the
negation, purchase or redemption of the Rights.
20
YOUR VOTE IS EXTREMELY IMPORTANT
1. Please SIGN, MARK, DATE and MAIL your BLUE consent in the enclosed
postage-paid envelope as soon as possible before _______, 1998. If you
wish to consent to the removal of the current Board of Directors, the
amendment of the Bylaws to set the number of directors, the election
of the Cycle Nominees and the repeal of any Bylaws adopted since April
30, 1997, you must submit the enclosed consent, even if you have
already submitted a consent card to any other person or entity
(including the Company).
2. If your shares are held for you by a bank or brokerage firm, only your
bank or broker can vote your shares and only after receiving
instructions from you. Please call your bank or broker and instruct
your representative to consent to the removal of the current Board of
Directors, the amendment of the Bylaws to set the number of directors,
the election of the Cycle Nominees and the repeal of any Bylaws
adopted since April 30, 1997 on the BLUE consent card.
3. Time is short. PLEASE VOTE TODAY!
If you have questions or need assistance in voting your shares or in
changing your vote, please contact Cycle at the number listed below:
c/o Innisfree M&A Incorporated
501 Madison Avenue, 20th Floor
New York, NY 10022
Call Toll-Free: (888) 750-5834
Banks and Brokers call collect: (212) 750-5833
21
APPENDIX
PRELIMINARY COPY
GLOBAL MOTORSPORT GROUP, INC.
CONSENT OF STOCKHOLDERS TO ACTION WITHOUT A MEETING:
THIS CONSENT IS SOLICITED BY GOLDEN CYCLE, LLC ("CYCLE")
The undersigned, a stockholder of record of GLOBAL MOTORSPORT GROUP,
INC. (the "Company"), hereby consents pursuant to Section 228 of the Delaware
General Corporation Law, with respect to the number of shares of Common Stock,
par value $0.001 per share, of the Company held by the undersigned, to each of
the following actions without a prior notice and without a vote as more fully
described in Cycle's consent statement (the "Consent Statement"), receipt of
which is hereby acknowledged.
CYCLE STRONGLY RECOMMENDS THAT STOCKHOLDERS CONSENT TO THE FOLLOWING
PROPOSALS:
1. Director Removal Proposal: Remove the current members of the Board of
Directors of the Company other than the directors elected by this
consent, pursuant to the resolution set forth in the Consent
Statement.
[ ] CONSENT [ ] CONSENT WITHHELD
[ ] ABSTAIN
If no box is marked with respect to the Director Removal Proposal, the
undersigned will be deemed to consent to the removal of the directors of the
Company as set forth above.
2. Board Size Proposal: Amend the Bylaws to set the number of directors
on the Board of Directors of the Company at five, pursuant to the
resolution set forth in the Consent Statement.
[ ] CONSENT [ ] CONSENT WITHHELD
[ ] ABSTAIN
If no box is marked with respect to the Board Size Proposal, the
undersigned will be deemed to consent to the amendment of the Bylaws as set
forth above.
3. Director Election Proposal: Elect the following five persons listed
below (the "Nominees") to fill the newly vacant directorships,
pursuant to the resolution set forth in the Consent Statement: Aaron
H. Brenner, Alexander Grass, Roger Grass, H. Irwin Levy, George
Lindemann
[ ] CONSENT [ ] CONSENT WITHHELD
[ ] ABSTAIN
To withhold consent to a proposed Nominee, specify the Nominee in the
following space:
If no box is marked above with respect to the Director Election
Proposal, the undersigned will be deemed to consent to the election of all five
Nominees.
4. Bylaw Proposal: Repeal any Bylaws adopted by the Board of Directors
since April 30, 1997 (other than the Bylaws adopted by this consent),
pursuant to the resolution set forth in the Consent Statement.
[ ] CONSENT [ ] CONSENT WITHHELD
[ ] ABSTAIN
If no box is marked with respect to the Bylaw Proposal, the undersigned
will be deemed to consent to the repeal of any Bylaws adopted since April 30,
1997 as set forth above.
PLEASE ACT PROMPTLY. IMPORTANT: THIS CONSENT MUST BE SIGNED AND DATED
TO BE VALID.
Dated: _________________________, 1998
Signature: _________________________
Signature
(if held jointly):________________________
Title or authority
(if applicable): ________________________
Please sign exactly as name appears hereon. If shares are registered in
more than one name, the signature of all such persons should be provided. A
corporation should sign in its full corporate name by a duly authorized officer,
stating his or her title. Trustees, guardians, executors and administrators
should sign in their official capacity, giving their full title as such. If a
partnership, please sign in the partnership name by authorized persons. The
consent card votes all shares in all capacities.
PLEASE MARK, SIGN AND DATE THIS CONSENT BEFORE MAILING THE CONSENT IN
THE ENCLOSED ENVELOPE.